APA (7th ed.) Citation

Burcu Özkan, Ebru Altuntaş, Ümmühan Ünlü, Hasan Hüseyin Doğan, Yıldız Özsoy, & Rabia Çakır Koç. (2023). Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus. MDPI AG.

Chicago Style (17th ed.) Citation

Burcu Özkan, Ebru Altuntaş, Ümmühan Ünlü, Hasan Hüseyin Doğan, Yıldız Özsoy, and Rabia Çakır Koç. Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative Against Respiratory Syncytial Virus. MDPI AG, 2023.

MLA (9th ed.) Citation

Burcu Özkan, et al. Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative Against Respiratory Syncytial Virus. MDPI AG, 2023.